JP2007530579A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530579A5
JP2007530579A5 JP2007505186A JP2007505186A JP2007530579A5 JP 2007530579 A5 JP2007530579 A5 JP 2007530579A5 JP 2007505186 A JP2007505186 A JP 2007505186A JP 2007505186 A JP2007505186 A JP 2007505186A JP 2007530579 A5 JP2007530579 A5 JP 2007530579A5
Authority
JP
Japan
Prior art keywords
group
alkyl
alkylene
heterocyclyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007505186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530579A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/009880 external-priority patent/WO2005094531A2/en
Publication of JP2007530579A publication Critical patent/JP2007530579A/ja
Publication of JP2007530579A5 publication Critical patent/JP2007530579A5/ja
Pending legal-status Critical Current

Links

JP2007505186A 2004-06-10 2005-03-24 アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン Pending JP2007530579A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57876904P 2004-06-10 2004-06-10
PCT/US2005/009880 WO2005094531A2 (en) 2004-03-24 2005-03-24 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines

Publications (2)

Publication Number Publication Date
JP2007530579A JP2007530579A (ja) 2007-11-01
JP2007530579A5 true JP2007530579A5 (https=) 2008-05-08

Family

ID=38769911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007505186A Pending JP2007530579A (ja) 2004-06-10 2005-03-24 アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン

Country Status (1)

Country Link
JP (1) JP2007530579A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793515B2 (en) 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
RU2010142655A (ru) * 2008-03-19 2012-04-27 Ауриммед Фарма, Инк. (Us) Соединение, пригодное для лечения болезней и нарушений центральной нервной системы, и способ его получения
US20210130285A1 (en) 2008-03-19 2021-05-06 Aurimmed Pharma, Inc. Novel compounds advantageous in the treatment of central nervous system diseases and disorders
EA026354B1 (ru) * 2012-08-24 2017-03-31 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Пиразолопиримидиновые соединения
TWI674261B (zh) * 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
US20230248835A1 (en) * 2020-07-08 2023-08-10 Purdue Research Foundation Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer

Similar Documents

Publication Publication Date Title
JP2007517044A5 (https=)
JP2007502288A5 (https=)
JP2007517035A5 (https=)
JP2007511527A5 (https=)
JP2007511535A5 (https=)
JP2007512349A5 (https=)
JP2008503484A5 (https=)
JP2008529974A5 (https=)
JP2008511677A5 (https=)
JP2007502293A5 (https=)
JP2007513170A5 (https=)
JP2007507542A5 (https=)
JP2007504161A5 (https=)
JP2007512370A5 (https=)
JP2008526754A5 (https=)
JP2012236838A5 (https=)
JP2007508305A5 (https=)
RU2006105101A (ru) Арилокси и арилалкиленокси замещенные имидазохинолины
JP2018525426A5 (https=)
JP2009507036A5 (https=)
JP2007530450A5 (https=)
JP2008530099A5 (https=)
DE50307267D1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP2008535831A5 (https=)
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation